REQUEST A DEMO
Total
USD $0.00
Search more companies

GM Pharma Kft. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: GM Pharma Gyogyszer- es Gyogyaszati Segedeszkoz Kereskedelmi Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

GM Pharma Kft. is based in Hungary, with the head office in Budaors. The company operates in the Pharmacies and Drug Stores industry. It was established on April 25, 2014. 3 (2024) employees currently work for GM Pharma Kft.. From the latest financial highlights, GM Pharma Kft. reported a net sales revenue increase of 4.9% in 2023. Its total assets grew by 30.54% over the same period. In 2023, GM Pharma Kft.’s net profit margin decreased by 4.52%.

Headquarters
Budapesti ut 105.
Budaors; Pest; Postal Code: 2040

Contact Details: Purchase the GM Pharma Kft. report to view the information.

Basic Information
Total Employees:
Purchase the GM Pharma Kft. report to view the information.
Outstanding Shares:
Purchase the GM Pharma Kft. report to view the information.
Registered Capital:
Purchase the GM Pharma Kft. report to view the information.
Incorporation Date:
April 25, 2014
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after GM Pharma Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
4.9%
Total operating revenue
5.58%
Operating profit (EBIT)
-57.4%
EBITDA
-52.33%
Net Profit (Loss) for the Period
-57.39%
Total assets
30.54%
Total equity
43.33%
Operating Profit Margin (ROS)
-5.12%
Net Profit Margin
-4.52%
Return on Equity (ROE)
-74.45%
Quick Ratio
0.11%
Cash Ratio
0.13%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?